Background and aims: Type 2 diabetes mellitus (T2DM) and pre-diabetes are characterized by abnormal post-prandial suppression of glucagon. Elevated circulating concentrations of some amino acids (AA) are markers of insulin resistance and of increased progression of pre-diabetes to T2DM. α-cells respond to elevated AA with increased glucagon secretion which in turn should stimulate hepatic AA catabolism. At present it is unknown if hyperglucagonemia represents an innate defect in α-cell responsiveness to AA. We sought to quantify the extent to which glucose-induced glucagon suppression is altered by AA. We also sought to ascertain whether this is an early change in the pathogenesis of pre-diabetes. Materials and methods: Subjects were studied on two occasions in random order after an overnight fast. On each day, a graded glucose infusion was used in conjunction with a saline infusion (Saline Day) or an AA mixture (Clinisol (15%, 0.003ml/kg/min; 51% essential AA, 18% branched-chain AA, 9% aromatic AA; Baxter, Healthcare, Deerfield, IL - AA day). The glucagon secretion rate (GSR) was derived by deconvolution from peripheral glucagon concentrations and G50 - the change in glucose required to reduce GSR by 50% - was calculated for each subject. Data are reported as mean ± standard error of the mean (SEM) with significant results indicated by p-value <0.05. Results: Participants studied to date (51.6 ± 3.6 years), were categorized based on body fat percentage as lean (<30%) and overweight or obese (≥35%). The relationship of GSR to glucose concentration is demonstrated in Figure 1. Lean participants (average body fat percentage = 27 ± 2%, BMI = 24 ± 2 kg/m2) showed no significant change in G50 in the presence and absence of AA respectively (1.7 ± 0.8 vs. 1.6 ± 0.7 mmol/L, p = 0.3). However, individuals with obesity (average body fat percentage = 43.6 ± 2.8%, BMI = 31 ± 1 kg/m2) showed significantly higher G50 when infused with AA compared to saline (2.2 ± 0.5 vs. 1.5 ± 0.4 mmol/L, p = 0.04). Conclusion: Obesity is associated with an increase in G50 in the presence of AA suggesting that obesity impairs α-cell suppression by hyperglycemia providing a potential explanation for glucagon elevation in obesity and T2DM.

The effect of obesity on the alpha cell response to amino acids in the presence of hyperglycaemia

Federica Boscolo;Chiara Dalla Man
;
2024

Abstract

Background and aims: Type 2 diabetes mellitus (T2DM) and pre-diabetes are characterized by abnormal post-prandial suppression of glucagon. Elevated circulating concentrations of some amino acids (AA) are markers of insulin resistance and of increased progression of pre-diabetes to T2DM. α-cells respond to elevated AA with increased glucagon secretion which in turn should stimulate hepatic AA catabolism. At present it is unknown if hyperglucagonemia represents an innate defect in α-cell responsiveness to AA. We sought to quantify the extent to which glucose-induced glucagon suppression is altered by AA. We also sought to ascertain whether this is an early change in the pathogenesis of pre-diabetes. Materials and methods: Subjects were studied on two occasions in random order after an overnight fast. On each day, a graded glucose infusion was used in conjunction with a saline infusion (Saline Day) or an AA mixture (Clinisol (15%, 0.003ml/kg/min; 51% essential AA, 18% branched-chain AA, 9% aromatic AA; Baxter, Healthcare, Deerfield, IL - AA day). The glucagon secretion rate (GSR) was derived by deconvolution from peripheral glucagon concentrations and G50 - the change in glucose required to reduce GSR by 50% - was calculated for each subject. Data are reported as mean ± standard error of the mean (SEM) with significant results indicated by p-value <0.05. Results: Participants studied to date (51.6 ± 3.6 years), were categorized based on body fat percentage as lean (<30%) and overweight or obese (≥35%). The relationship of GSR to glucose concentration is demonstrated in Figure 1. Lean participants (average body fat percentage = 27 ± 2%, BMI = 24 ± 2 kg/m2) showed no significant change in G50 in the presence and absence of AA respectively (1.7 ± 0.8 vs. 1.6 ± 0.7 mmol/L, p = 0.3). However, individuals with obesity (average body fat percentage = 43.6 ± 2.8%, BMI = 31 ± 1 kg/m2) showed significantly higher G50 when infused with AA compared to saline (2.2 ± 0.5 vs. 1.5 ± 0.4 mmol/L, p = 0.04). Conclusion: Obesity is associated with an increase in G50 in the presence of AA suggesting that obesity impairs α-cell suppression by hyperglycemia providing a potential explanation for glucagon elevation in obesity and T2DM.
2024
60th European Association for the Study of Diabetes Annual Meeting
60th European Association for the Study of Diabetes Annual Meeting
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3537599
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact